WestHill Financial Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,160
Closed -$245K 79
2024
Q3
$245K Buy
2,160
+76
+4% +$9.03K 0.06% 65
2024
Q2
$258K Sell
2,084
-231
-10% -$29.8K 0.06% 60
2024
Q1
$305K Buy
2,315
+335
+17% +$41.3K 0.08% 57
2023
Q4
$216K Sell
1,980
-68
-3% -$7.06K 0.06% 67
2023
Q3
$211K Hold
2,048
0.06% 63
2023
Q2
$236K Sell
2,048
-86
-4% -$9.77K 0.07% 55
2023
Q1
$227K Sell
2,134
-250
-10% -$27K 0.07% 55
2022
Q4
$265K Buy
+2,384
New +$244K 0.08% 50

Other funds holding MRK

WestHill Financial Advisors's MRK Position: Q4 2024 in Review

WestHill Financial Advisors sold out of Merck (MRK) in Q4 2024, closing a stake of 2,160 shares — an estimated $245K sold.

WestHill Financial Advisors first reported a position in MRK in Q4 2022 and held it in 8 quarters. The position peaked at $305K in Q1 2024. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • WestHill Financial Advisors reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
  • WestHill Financial Advisors sold 2,160 Merck shares in Q4 2024, an estimated $245K.
  • WestHill Financial Advisors first reported a position in Merck in Q4 2022 and held it in 8 quarters.
  • WestHill Financial Advisors's Merck position peaked at $305K in Q1 2024.
  • 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on WestHill Financial Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.